flag_yellow_high | Penta

Home
About Us
Our activities
News & Events
- COVID-19 pandemic
- News
- Press Releases
- Events
- Stories
- Scientific Views
- PIM
Publications
Contact us
Reserved area
Work with us
- Vacancies
- Call for services

flag_yellow_high

Tags: | March 17th, 2018

Publication policy

Penta Publication Policy

Recent News

International Workshop on HIV Pediatrics now accepting abstracts!
Carlo Giaquinto and Francesco Bonfante talk about Covid 19 testing at Penta
Penta coordinates new European-African Project that will develop UNIVERSAL treatments for children living with HIV
Farewell to a great man
Prof. Timo Vesikari talks to us about COVID-19 vaccines and children

Categories

Meetings and events
Guidelines
Study update
Education
New projects

Categories

Respiratory Viruses
Penta HIV guidelines
HIV
- REACH
- EPIICAL
- EPPICC
  - 2020
  - 2019
  - 2018
  - 2017
  - 2016
  - 2014
  - 2013
  - 2011
- PANNA
- REALITY
- Penta HIV Trials
  - PENTA 20 (Odyssey)
  - PENTA 18 (Koncert)
  - PENTA 16 (BREATHER)
  - PENTA 15
  - PENTA 13
  - PENTA 11
  - PENTA 9
  - PENTA 8 (PERA)
  - PENTA 7
  - PENTA 5
  - PENTA 4
  - PENTA 3
  - PENTA 1
- Other HIV publications
Other viruses
- COVID-19
- CMV
- HCV
- Zika
Antimicrobials
- NeoVanc
Antifungals
Network building
- c4c

Tags

AFRICA
Carlo Giaquinto
Clinical trials
EPIICAL
NeoVanc
Prepare
Tr@inforPedHIV
Tr@inforPedHIV
Training
ZIKAction

Project Publications

ZIKAction
EPIICAL
ODYSSEY
c4c

Contacts

Corso Stati Uniti 4
35127 Padova
Italy

VAT 04150680280

info@penta-id.org

fondazionepenta@pec.it

+39 049 7169822

Fondazione Penta ONLUS

Recent publications

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing
2 weeks ago
Harmonising regulatory approval for antibiotics in children
1 month ago
Zika virus infection in pregnancy: a protocol for the join analysis of the prospective cohort studies of the ZIKAlliance, ZikaPLAN and ZIKAction consortia
2 months ago
A population pharmacokinetics analysis assessing the exposure of raltegravir once‐daily 1200mg in pregnant women living with HIV
2 months ago

Tweets by Penta_ID

Copyright © 2019 Fondazione Penta ONLUS. All rights reserved. Privacy - Credits

NEWSLETTER

We would like to update you on our recent activities

No thanks, I’m not interested!